title: Intravenous infusion of iron and tetrahydrofolate does not influence intrauterine uteroferrin and secreted folate-binding protein content in swine.
abstract: The effect of exogenous iron and folate on reproductive performance in swine is equivocal. However, the effect of exogenous iron and folate on secretion of their respective uterine transport proteins has never been reported. Twenty gilts were infused (n = 5 per treatment) with either 1) saline, 2) alpha-tocopherol, 3) alpha-tocopherol plus iron citrate, or 4) alpha-tocopherol plus tetrahydrofolate on d 11 to 14 of pregnancy. Intravenous infusion of iron citrate and tetrahydrofolate increased (P < 0.05) plasma iron and folate, respectively, for 6 to 8 h after treatment. Treatments had no effect on uterine content of uteroferrin or secreted folate-binding protein in uterine flushings obtained on d 15 of pregnancy. These data suggest that uterine secretion of uteroferrin and secreted folate-binding protein are not influenced by plasma levels of iron and folate, respectively, and may provide an explanation for the equivocal effect of iron and folate treatment on reproductive performance in gilts.
authors.affiliation: USDA, ARS, Roman L. Hruska U.S. Meat Animal Research Center, Clay Center, NE 68933, USA. vallet@email.marc.usda.gov
authors.forename: J L
authors.initials: JL
authors.lastname: Vallet
authors.forename: R K
authors.initials: RK
authors.lastname: Christenson
authors.forename: H G
authors.initials: HG
authors.lastname: Klemcke
authors.forename: P L
authors.initials: PL
authors.lastname: Pearson
mesh_terms: D000135:Acid Phosphatase / Q000032:analysis; D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism*; D005260:Female; D058973:Folate Receptors, GPI-Anchored; D007262:Infusions, Intravenous / Q000662:veterinary; D007501:Iron / Q000008:administration & dosage* / Q000494:pharmacology; D007527:Isoenzymes; D008667:Metalloproteins / Q000378:metabolism*; D011247:Pregnancy; D011956:Receptors, Cell Surface; D012177:Retinol-Binding Proteins / Q000032:analysis; D054839:Retinol-Binding Proteins, Plasma; D013552:Swine / Q000378:metabolism*; D000071681:Tartrate-Resistant Acid Phosphatase; D013763:Tetrahydrofolates / Q000008:administration & dosage* / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects / Q000378:metabolism*; D014810:Vitamin E / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D002352:Carrier Proteins; D058973:Folate Receptors, GPI-Anchored; D007527:Isoenzymes; D008667:Metalloproteins; D011956:Receptors, Cell Surface; D012177:Retinol-Binding Proteins; D054839:Retinol-Binding Proteins, Plasma; D013763:Tetrahydrofolates; D014810:Vitamin E; C030371:5,6,7,8-tetrahydrofolic acid; D007501:Iron; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase